4D MOLECULAR THERAPEUTICS IN (FDMT)
US35104E1001 - Common Stock
ChartMill assigns a Buy % Consensus number of 85% to FDMT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 50.32. This target is 98.89% above the current price.
FDMT was analyzed by 16 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about FDMT.
In the previous month the buy percentage consensus was at a similar level.
FDMT was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-15 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-04-15 | Barclays | Initiate | Overweight |
| 2024-04-01 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-04-01 | Jefferies | Maintains | Buy -> Buy |
| 2024-03-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-07 | Goldman Sachs | Reiterate | Buy |
| 2024-02-05 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-02-05 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-01-29 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-10-24 | Cantor Fitzgerald | Initiate | Overweight |
| 2023-08-11 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-08-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-11 | Chardan Capital | Maintains | Buy -> Buy |
| 2023-07-05 | Chardan Capital | Initiate | Buy |
| 2023-06-08 | B of A Securities | Maintains | Buy |
| 2023-06-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-28 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-13 | SVB Securities | Maintains | Market Perform |
| 2023-03-16 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-23 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-06 | SVB Leerink | Maintains | Market Perform |
| 2023-02-06 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-30 | BMO Capital | Initiate | Outperform |
| 2022-11-18 | HC Wainwright & Co. | Initiate | Buy |
| 2022-11-15 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2022-11-14 | SVB Leerink | Maintains | Market Perform |
| 2022-11-10 | SVB Leerink | Maintains | Market Perform |
| 2022-08-12 | SVB Leerink | Downgrade | Outperform -> Market Perform |